The study reveals that ARK1 controls spindle formation during malaria parasite division. Blocking this protein disrupted parasite replication and prevented development within hosts, offering a new ...

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...

Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a ...

Malaria drugs are failing at an "alarming" rate in Southeast Asia as drug-resistant strains of the malaria parasite emerge. Global health officials get nervous when new strains of drug-resistant ...

Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...

Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...

Patients who are infected with malaria and dengue virus receive treatment in an isolation ward at a hospital in Pakistan. Drugs known as artemisinins have been remarkably effective in helping malaria ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...